Skip Navigation


JAC Advance Access originally published online on September 1, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
52/4/724    most recent
dkg396v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Giacometti, A.
Right arrow Articles by Scalise, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giacometti, A.
Right arrow Articles by Scalise, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 52, 724-726
© 2003 The British Society for Antimicrobial Chemotherapy

Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides

Andrea Giacometti1,*, Roberto Ghiselli2, Oscar Cirioni1, Federico Mocchegiani2, Fiorenza Orlando3, Maria Simona Del Prete1, Giuseppina D’Amato1, Carmela Silvestri1, Vittorio Saba2 and Giorgio Scalise1

1 Institute of Infectious Diseases and Public Health, University of Ancona, Ancona; 2 Department of General Surgery, I.N.R.C.A. I.R.C.C.S., University of Ancona, Ancona; 3 Biotechnology Centre, Research Department, I.N.R.C.A. I.R.R.C.S., Ancona, Italy

Received 27 March 2003; returned 21 May 2003; revised 20 June 2003; accepted 29 June 2003

Objectives: A rat model was used to investigate the efficacy of linezolid, alone or in combination with levofloxacin and vancomycin, in the prevention of vascular prosthetic graft infection resulting from methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides.

Methods: Graft infections were established in the subcutaneous tissue of adult male Wistar rats by implantation of Dacron prostheses, followed by topical inoculation with S. epidermidis. The study comprised: one group without inoculation; one inoculated group without prophylaxis; six inoculated groups that received intraperitoneal linezolid (8 mg/kg), levofloxacin (7 mg/kg) or vancomycin (7 mg/kg) alone or in combination at the dosages mentioned above. Each group included 20 animals. The grafts were removed after 7 days and evaluated by quantitative culture.

Results: Quantitative graft cultures from animals treated with a single drug showed a significant efficacy only for linezolid. The efficacy of levofloxacin was similar to that of vancomycin. Combination studies demonstrated that only the treatments that included linezolid produced no evidence of staphylococcal infection.

Conclusions: Linezolid as perioperative prophylaxis can be useful for the prevention of graft infections caused by multiresistant staphylococcal strains.

Keywords: antibiotic prophylaxis, oxazolidinones, vascular surgery, GISE

* Correspondence address. Clinica Malattie Infettive, c/o Ospedale Regionale, via Conca, 60020 Ancona, Italy. Tel: +39-071-5963715; Fax: +39-071-5963468; E-mail: anconacmi{at}interfree.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Journal of Bioactive and Compatible PolymersHome page
C. Agalar, D. Kilic, S. Ceken, M. Ozdogan, E. Yasar, E. Ozturk, and E. Baki DenkbaS
Inhibition of Staphylococcus Epidermidis Colonization with Fusidic Acid-Impregnated Catheters
Journal of Bioactive and Compatible Polymers, March 1, 2007; 22(2): 160 - 173.
[Abstract] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
G. Athanassopoulos, A. Pefanis, V. Sakka, D. Iliopoulos, D. Perrea, and H. Giamarellou
Linezolid in Prophylaxis against Experimental Aortic Valve Endocarditis Due to Streptococcus oralis or Enterococcus faecalis
Antimicrob. Agents Chemother., February 1, 2006; 50(2): 654 - 657.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.